SEC Form 4 · accession 0001434647-26-000070
ZEVRA THERAPEUTICS, INC. · ZVRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Corey Michael Watton
Director
Period of report
Aug 10, 2026
Accepted (ET)
Aug 12, 2026 · 4:16 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001434647
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 10, 2026 | M | 12,300 | $4.97 | A | 14,100 | D | |
| Common StockF1 | Aug 10, 2026 | S | 12,300 | $11.2502 | D | 1,800 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $4.97 | Aug 10, 2026 | M | 12,300 | D | — | May 2, 2033 | Common Stock | 12,300 | 46,500 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $11.23 to $11.31. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2The shares underlying this option, which was granted on May 3, 2023, were fully vested.